STRONG BUY GETING TO $0.72 A SHARE https://globenewswire.com/news-release/2017/09/28/1134264/0/en/Galena-Biopharma-Announces-Completion-of-Enrollment-in-Two-NeuVax-nelipepimut-S-Clinical-Trials-in-Combination-with-Trastuzumab.html